These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 870178
1. Pharmacology of 5'-esters of 1-beta-D-arabinofuranosylcytosine. Ho DH, Neil GL. Cancer Res; 1977 Jun; 37(6):1640-3. PubMed ID: 870178 [Abstract] [Full Text] [Related]
2. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice. Hori K, Tsuruo T, Naganuma K, Tsukagoshi S, Sakurai Y. Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034 [Abstract] [Full Text] [Related]
3. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid. Hong CI, Bernacki RJ, Hui SW, Rustum Y, West CR. Cancer Res; 1990 Jul 15; 50(14):4401-6. PubMed ID: 2364392 [Abstract] [Full Text] [Related]
4. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance. Oh-ishi J, Kataoka T, Tsukagoshi S, Sakurai Y, Shibukawa M, Kobayashi H. Cancer Res; 1981 Jun 15; 41(6):2501-6. PubMed ID: 7237444 [Abstract] [Full Text] [Related]
5. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative. Kato Y, Saito M, Fukushima H, Takeda Y, Hara T. Cancer Res; 1984 Jan 15; 44(1):25-30. PubMed ID: 6197162 [Abstract] [Full Text] [Related]
6. Methotrexate-induced changes in the levels of 1-beta-D-arabinofuranosylcytosine triphosphate in L1210 cells. Roberts D, Peck C, Hilliard S, Wingo W. Cancer Res; 1979 Oct 15; 39(10):4048-54. PubMed ID: 476642 [Abstract] [Full Text] [Related]
7. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo. Chou TC, Hutchinson DJ, Schmid FA, Philips FS. Cancer Res; 1975 Jan 15; 35(1):225-36. PubMed ID: 1109791 [Abstract] [Full Text] [Related]
8. Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles. Mayhew E, Papahadjopoulos D, Rustum YM, Dave C. Cancer Res; 1976 Dec 15; 36(12):4406-11. PubMed ID: 187321 [Abstract] [Full Text] [Related]
9. Metabolism of the new liposomal anticancer drug N4-octadecyl-1-beta-D-arabinofuranosylcytosine in mice. Koller-Lucae SK, Suter MJ, Rentsch KM, Schott H, Schwendener RA. Drug Metab Dispos; 1999 Mar 15; 27(3):342-50. PubMed ID: 10064564 [Abstract] [Full Text] [Related]
10. Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia. Colly LP, Peters WG, Willemze R. Cancer Res; 1986 Aug 15; 46(8):3825-7. PubMed ID: 3460691 [Abstract] [Full Text] [Related]
11. Therapy of central nervous system leukemia in mice by liposome-entrapped 1-beta-D-arabinofuranosylcytosine. Hong F, Mayhew E. Cancer Res; 1989 Sep 15; 49(18):5097-102. PubMed ID: 2766280 [Abstract] [Full Text] [Related]
12. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology. Early AP, Preisler HD, Slocum H, Rustum YM. Cancer Res; 1982 Apr 15; 42(4):1587-94. PubMed ID: 6949642 [Abstract] [Full Text] [Related]
13. Combination chemotherapy of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine. Neil GL, Berger AE, Bhuyan BK, DeSante DC. Cancer Res; 1976 Mar 15; 36(3):1114-20. PubMed ID: 56229 [Abstract] [Full Text] [Related]
14. Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine. Ueda T, Kamiya K, Urasaki Y, Wataya S, Kawai Y, Tsutani H, Sugiyama M, Nakamura T. Cancer Res; 1994 Jan 01; 54(1):109-13. PubMed ID: 8261429 [Abstract] [Full Text] [Related]
15. [Antitumor activity of a novel analog of cytarabine, 4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 5'-(sodium octadecyl phosphate) monohydrate (YNK01)]. Nagahata T, Shibasaki C, Ishii T, Uchida T, Arakawa M, Kusama K, Ekimoto H, Takahashi K. Gan To Kagaku Ryoho; 1990 Aug 01; 17(8 Pt 1):1437-45. PubMed ID: 2389942 [Abstract] [Full Text] [Related]
16. Phospholipid derivatives of nucleoside analogs as prodrugs with enhanced catabolic stability. Matsushita T, Ryu EK, Hong CI, MacCoss M. Cancer Res; 1981 Jul 01; 41(7):2707-13. PubMed ID: 7248939 [Abstract] [Full Text] [Related]
17. Effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on pools of deoxyribonucleoside triphosphates in L1210 ascites cells. Roberts D, Peck C. Cancer Res; 1981 Feb 01; 41(2):505-10. PubMed ID: 7448798 [Abstract] [Full Text] [Related]
18. Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine. Liliemark JO, Plunkett W, Dixon DO. Cancer Res; 1985 Nov 01; 45(11 Pt 2):5952-7. PubMed ID: 4053067 [Abstract] [Full Text] [Related]
19. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy. Plunkett W, Liliemark JO, Adams TM, Nowak B, Estey E, Kantarjian H, Keating MJ. Cancer Res; 1987 Jun 01; 47(11):3005-11. PubMed ID: 3471322 [Abstract] [Full Text] [Related]
20. Combination therapy of mouse leukemia L1210 by 1-beta-D-arabinofuranosylcytosine and 6-[(4-nitrobenzyl)thio]-9-beta-D-ribofuranosylpurine. Cass CE, Muzik H, Paterson AR. Cancer Res; 1975 May 01; 35(5):1187-93. PubMed ID: 1120308 [Abstract] [Full Text] [Related] Page: [Next] [New Search]